메뉴 건너뛰기




Volumn 39, Issue 5, 2009, Pages 190-197

Efficacy of triple anti-platelet therapy including cilostazol in acute myocardial infarction patients undergoing drug-eluting stent implantation

Author keywords

Drug eluting stents; Myocardial infarction; Platelets

Indexed keywords

ACETYLSALICYLIC ACID; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CILOSTAZOL; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN RECEPTOR ANTAGONIST;

EID: 67649109740     PISSN: 17385520     EISSN: 17385555     Source Type: Journal    
DOI: 10.4070/kcj.2009.39.5.190     Document Type: Article
Times cited : (10)

References (30)
  • 1
    • 42649119442 scopus 로고    scopus 로고
    • Clinical safety of drug-eluting stents in the Korea acute myocardial infarction registry
    • Lee SR, Jeong MH, Ahn YK, et al. Clinical safety of drug-eluting stents in the Korea acute myocardial infarction registry. Circ J 2008;72:392-398
    • (2008) Circ J , vol.72 , pp. 392-398
    • Lee, S.R.1    Jeong, M.H.2    Ahn, Y.K.3
  • 2
    • 34247128625 scopus 로고    scopus 로고
    • Meta-analysis of clinical trials on use of drug-eluting stents for treatment of acute myocardial infarction
    • Pasceri V, Patti G, Speciale G, Pristipino C, Richichi G, Di Sciascio G. Meta-analysis of clinical trials on use of drug-eluting stents for treatment of acute myocardial infarction. Am Heart J 2007;153:749-754
    • (2007) Am Heart J , vol.153 , pp. 749-754
    • Pasceri, V.1    Patti, G.2    Speciale, G.3    Pristipino, C.4    Richichi, G.5    Di Sciascio, G.6
  • 3
    • 38749108516 scopus 로고    scopus 로고
    • Drug-eluting stents: A critique
    • Melikian N, Wijns W. Drug-eluting stents: a critique. Heart 2008;94:145-152
    • (2008) Heart , vol.94 , pp. 145-152
    • Melikian, N.1    Wijns, W.2
  • 4
    • 38049183243 scopus 로고    scopus 로고
    • 2007 Focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 writing group to review new evidence and update the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction, writing on behalf of the 2004 writing committee
    • Antman EM, Hand M, Armstrong PW, et al. 2007 Focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 writing group to review new evidence and update the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction, writing on behalf of the 2004 writing committee. Circulation 2008;117:296-329.
    • (2008) Circulation , vol.117 , pp. 296-329
    • Antman, E.M.1    Hand, M.2    Armstrong, P.W.3
  • 5
    • 33144482404 scopus 로고    scopus 로고
    • Cilostazol: Potential mechanism of action for antithrombotic effects accompanied by a low rate of bleeding
    • Goto S. Cilostazol: potential mechanism of action for antithrombotic effects accompanied by a low rate of bleeding. Atheroscler Suppl 2005;6:3-11.
    • (2005) Atheroscler Suppl , vol.6 , pp. 3-11
    • Goto, S.1
  • 6
    • 32944470493 scopus 로고    scopus 로고
    • Role of adjunct pharmacologic therapy in the era of drug-eluting stents
    • Douglas JS Jr. Role of adjunct pharmacologic therapy in the era of drug-eluting stents. Atheroscler Suppl 2005;6:47-52.
    • (2005) Atheroscler Suppl , vol.6 , pp. 47-52
    • Douglas Jr., J.S.1
  • 7
    • 27844463244 scopus 로고    scopus 로고
    • Coronary stent restenosis in patients treated with cilostazol
    • Douglas JS Jr, Holmes DR Jr, Kereiakes DJ, et al. Coronary stent restenosis in patients treated with cilostazol. Circulation 2005;112:2826-2832
    • (2005) Circulation , vol.112 , pp. 2826-2832
    • Douglas Jr., J.S.1    Holmes Jr., D.R.2    Kereiakes, D.J.3
  • 8
    • 27644555633 scopus 로고    scopus 로고
    • Triple versus dual antiplatelet therapy after coronary stenting: Impact on stent thrombosis
    • Lee SW, Park SW, Hong MK, et al. Triple versus dual antiplatelet therapy after coronary stenting: impact on stent thrombosis. J Am Coll Cardiol 2005;46:1833-1837
    • (2005) J Am Coll Cardiol , vol.46 , pp. 1833-1837
    • Lee, S.W.1    Park, S.W.2    Hong, M.K.3
  • 9
    • 39849087752 scopus 로고    scopus 로고
    • Randomized comparison of cilostazol vs clopidogrel after drug-eluting stenting in diabetic patients: Clilostazol for diabetic patients in drug-eluting stent (CIDES) trial
    • Ahn Y, Jeong MH, Jeong JW, et al. Randomized comparison of cilostazol vs clopidogrel after drug-eluting stenting in diabetic patients: clilostazol for diabetic patients in drug-eluting stent (CIDES) trial. Circ J 2008;72:35-39
    • (2008) Circ J , vol.72 , pp. 35-39
    • Ahn, Y.1    Jeong, M.H.2    Jeong, J.W.3
  • 10
    • 40749126089 scopus 로고    scopus 로고
    • Drug-eluting stenting followed by cilostazol treatment reduces late restenosis in patients with diabetes mellitus the DECLARE-DIABETES Trial (A Randomized Comparison of Triple Antiplatelet Therapy with Dual Antiplatelet Therapy after Drug-Eluting Stent Implantation in Diabetic Patients)
    • Lee SW, Park SW, Kim YH, et al. Drug-eluting stenting followed by cilostazol treatment reduces late restenosis in patients with diabetes mellitus the DECLARE-DIABETES Trial (A Randomized Comparison of Triple Antiplatelet Therapy with Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Diabetic Patients). J Am Coll Cardiol 2008;51:1181-1187
    • (2008) J Am Coll Cardiol , vol.51 , pp. 1181-1187
    • Lee, S.W.1    Park, S.W.2    Kim, Y.H.3
  • 12
    • 0023864355 scopus 로고
    • Thrombolysis in Myocardial Infarction (TIMI) Trial: Phase I. hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase
    • Rao AK, Pratt C, Berke A, et al. Thrombolysis in Myocardial Infarction (TIMI) Trial: phase I. hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase. J Am Coll Cardiol 1988;11:1-11.
    • (1988) J Am Coll Cardiol , vol.11 , pp. 1-11
    • Rao, A.K.1    Pratt, C.2    Berke, A.3
  • 13
    • 52649151888 scopus 로고    scopus 로고
    • Drug-eluting or bare-metal stents for acute myocardial infarction
    • Mauri L, Silbaugh TS, Garg P, et al. Drug-eluting or bare-metal stents for acute myocardial infarction. N Engl J Med 2008;359:1330-1342
    • (2008) N Engl J Med , vol.359 , pp. 1330-1342
    • Mauri, L.1    Silbaugh, T.S.2    Garg, P.3
  • 14
    • 54049125008 scopus 로고    scopus 로고
    • Delayed arterial healing and increased late stent thrombosis at culprit sites after drug-eluting stent placement for acute myocardial infarction: An autopsy study
    • Nakazawa G, Finn AV, Joner M, et al. Delayed arterial healing and increased late stent thrombosis at culprit sites after drug-eluting stent placement for acute myocardial infarction: an autopsy study. Circulation 2008;118:1138-1145
    • (2008) Circulation , vol.118 , pp. 1138-1145
    • Nakazawa, G.1    Finn, A.V.2    Joner, M.3
  • 15
    • 33847736642 scopus 로고    scopus 로고
    • Safety and efficacy of sirolimus- And paclitaxel-eluting coronary stents
    • Stone GW, Moses JW, Ellis SG, et al. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med 2007;356:998-1008.
    • (2007) N Engl J Med , vol.356 , pp. 998-1008
    • Stone, G.W.1    Moses, J.W.2    Ellis, S.G.3
  • 16
    • 33644625730 scopus 로고    scopus 로고
    • The clinical results of a platelet glycoprotein IIb/IIIa receptor blocker (abciximab: ReoPro)-coated stent in acute myocardial infarction
    • Kim W, Jeong MH, Kim KH, et al. The clinical results of a platelet glycoprotein IIb/IIIa receptor blocker (abciximab: ReoPro)-coated stent in acute myocardial infarction. J Am Coll Cardiol 2006;47:933-938
    • (2006) J Am Coll Cardiol , vol.47 , pp. 933-938
    • Kim, W.1    Jeong, M.H.2    Kim, K.H.3
  • 17
    • 34248553815 scopus 로고    scopus 로고
    • New drug-eluting stents under study
    • Mitka M. New drug-eluting stents under study. JAMA 2007;297:2064-2067
    • (2007) JAMA , vol.297 , pp. 2064-2067
    • Mitka, M.1
  • 18
    • 0035908781 scopus 로고    scopus 로고
    • Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: The PCI-CURE study
    • Mehta SR, Yusuf S, Peters RJ, et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 2001;358:527-533
    • (2001) Lancet , vol.358 , pp. 527-533
    • Mehta, S.R.1    Yusuf, S.2    Peters, R.J.3
  • 19
    • 0035899289 scopus 로고    scopus 로고
    • Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation
    • Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001;345:494-502.
    • (2001) N Engl J Med , vol.345 , pp. 494-502
    • Yusuf, S.1    Zhao, F.2    Mehta, S.R.3    Chrolavicius, S.4    Tognoni, G.5    Fox, K.K.6
  • 20
    • 0023944556 scopus 로고
    • Effects of cilostazol, a selective cAMP phosphodiesterase inhibitor on the contraction of vascular smooth muscle
    • Tanaka T, Ishikawa T, Hagiwara M, Onoda K, Itoh H, Hidaka H. Effects of cilostazol, a selective cAMP phosphodiesterase inhibitor on the contraction of vascular smooth muscle. Pharmacology 1988;36:313-320
    • (1988) Pharmacology , vol.36 , pp. 313-320
    • Tanaka, T.1    Ishikawa, T.2    Hagiwara, M.3    Onoda, K.4    Itoh, H.5    Hidaka, H.6
  • 21
    • 34548253876 scopus 로고    scopus 로고
    • Effects of cilostazol treatment on angiographic restenosis after coronary stent placement
    • Chu YH, Park SW, Lee CW, et al. Effects of cilostazol treatment on angiographic restenosis after coronary stent placement. Korean Circ J 2000;30:1494-1500
    • (2000) Korean Circ J , vol.30 , pp. 1494-1500
    • Chu, Y.H.1    Park, S.W.2    Lee, C.W.3
  • 22
    • 0023195289 scopus 로고
    • Comparison of the inhibitory effects of cilostazol, acetylsalicylic acid and ticlopidine on platelet functions ex vivo: Randomized, double-blind cross-over study
    • Ikeda Y, Kikuchi M, Murakami H, et al. Comparison of the inhibitory effects of cilostazol, acetylsalicylic acid and ticlopidine on platelet functions ex vivo: randomized, double-blind cross-over study. Arzneimittelforschung 1987:37:563-566
    • (1987) Arzneimittelforschung , vol.37 , pp. 563-566
    • Ikeda, Y.1    Kikuchi, M.2    Murakami, H.3
  • 23
    • 14844328650 scopus 로고    scopus 로고
    • Effects of cilostazol on platelet activation in coronary stenting patients who already treated with aspirin and Clopidogrel
    • Ahn JC, Song WH, Kwon JA, et al. Effects of cilostazol on platelet activation in coronary stenting patients who already treated with aspirin and Clopidogrel. Korean J Intern Med 2004;19:230-236
    • (2004) Korean J Intern Med , vol.19 , pp. 230-236
    • Ahn, J.C.1    Song, W.H.2    Kwon, J.A.3
  • 24
    • 34548277570 scopus 로고    scopus 로고
    • Effect of cilostazol on the drug-eluting stent in native coronary arteries
    • Kim SM, Kim DI, Cho HJ, et al. Effect of cilostazol on the drug-eluting stent in native coronary arteries. Korean Circ J 2007;37-304-311
    • (2007) Korean Circ J , vol.37 , pp. 304-311
    • Kim, S.M.1    Kim, D.I.2    Cho, H.J.3
  • 25
    • 0026690069 scopus 로고
    • Effect of cilostazol, a cyclic AMP phosphodiesterase inhibitor, on the proliferation of rat aortic smooth muscle cells in culture
    • Takahashi S, Oida K, Fujiwara R, et al. Effect of cilostazol, a cyclic AMP phosphodiesterase inhibitor, on the proliferation of rat aortic smooth muscle cells in culture. J Cardiovasc Pharmacol 1992;20:900-906
    • (1992) J Cardiovasc Pharmacol , vol.20 , pp. 900-906
    • Takahashi, S.1    Oida, K.2    Fujiwara, R.3
  • 26
    • 34548251368 scopus 로고    scopus 로고
    • The effect of cilostazol on proliferation of vascular smooth muscle cells and expression of iNOS and p21
    • Lee KJ, Yun SW, Kim SW, Kim TH, Kim CJ, Ryu WS. The effect of cilostazol on proliferation of vascular smooth muscle cells and expression of iNOS and p21. Korean Cir J 2004;34:500-506
    • (2004) Korean Cir J , vol.34 , pp. 500-506
    • Lee, K.J.1    Yun, S.W.2    Kim, S.W.3    Kim, T.H.4    Kim, C.J.5    Ryu, W.S.6
  • 27
    • 32944461243 scopus 로고    scopus 로고
    • A scientific rationale for the CREST trial results: Evidence for the mechanism of action of cilostazol in restenosis
    • Morishita R. A scientific rationale for the CREST trial results: evidence for the mechanism of action of cilostazol in restenosis. Atheroscler Suppl 2005;6:41-46
    • (2005) Atheroscler Suppl , vol.6 , pp. 41-46
    • Morishita, R.1
  • 28
    • 34548633702 scopus 로고    scopus 로고
    • Comparison of triple versus dual antiplatelet therapy after drug-eluting stent implantation (from the DECLARE-Long trial)
    • Lee SW, Park SW, Kim YH, et al. Comparison of triple versus dual antiplatelet therapy after drug-eluting stent implantation (from the DECLARE-Long trial). Am J Cardiol 2007;100:1103-1108
    • (2007) Am J Cardiol , vol.100 , pp. 1103-1108
    • Lee, S.W.1    Park, S.W.2    Kim, Y.H.3
  • 29
    • 3042718111 scopus 로고    scopus 로고
    • Atherothrombosis: A widespread disease with unpredictable and life-threatening consequences
    • Viles-Gonzalez JF, Fuster V, Badimon JJ. Atherothrombosis: a widespread disease with unpredictable and life-threatening consequences. Eur Heart J 2004;25:1197-1207
    • (2004) Eur Heart J , vol.25 , pp. 1197-1207
    • Viles-Gonzalez, J.F.1    Fuster, V.2    Badimon, J.J.3
  • 30
    • 20044366366 scopus 로고    scopus 로고
    • Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation
    • Ong AT, Hoye A, Aoki J, et al. Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation. J Am Coll Cardiol 2005;45:947-953
    • (2005) J Am Coll Cardiol , vol.45 , pp. 947-953
    • Ong, A.T.1    Hoye, A.2    Aoki, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.